Showing 1 - 10 of 12,507
We conducted a choice experiment presenting respondents with risk reductions for three types of illnesses related to air pollution—pollen allergy, chronic bronchitis, and lung cancer—splitting the sample to test the effects of private-good and public-good contexts on the value of a...
Persistent link: https://www.econbiz.de/10005442427
Persistent link: https://www.econbiz.de/10001429362
In International Economics, so-called gravity equation has been successful. In the present paper, we show that similar equation concerning transaction network holds well. The weight of transaction network among Japanese prefectures is explained by Sales-i*Sales-j/Distance-ij very well. The...
Persistent link: https://www.econbiz.de/10012706981
Persistent link: https://www.econbiz.de/10013271796
Persistent link: https://www.econbiz.de/10014468793
Persistent link: https://www.econbiz.de/10014469926
We propose a novel framework to analyse the macroeconomic impact of non-communicable diseases. We incorporate measures of disease prevalence into a human capital augmented production function, which enables us to determine the economic costs of chronic health conditions in terms of foregone...
Persistent link: https://www.econbiz.de/10011704338
This Article explains the significance in Japan, hitherto little noticed elsewhere, of criminal law in regulating medical practice. The Article offers reasons of law and social structure for criminal law's role in Japanese medicine, reasons stemming in large part from the weakness of other...
Persistent link: https://www.econbiz.de/10014211982
The health of the vulnerable populations receiving the Long-Term Care (LTC) Insurance Programs threatened by the direct and indirect effects of disasters. The 2011 Great East Japan Earthquake and tsunami, and the explosion at the Fukushima Daiichi nuclear power plant (FDNPP) forced the...
Persistent link: https://www.econbiz.de/10014259604
We propose a novel framework to analyse the macroeconomic impact of noncommunicable diseases. We incorporate measures of disease prevalence into a human capital augmented production function, which enables us to determine the economic costs of chronic health conditions in terms of foregone gross...
Persistent link: https://www.econbiz.de/10011653537